ID   TPIS_HUMAN              Reviewed;         286 AA.
AC   P60174; B7Z5D8; D3DUS9; P00938; Q6FHP9; Q6IS07; Q8WWD0; Q96AG5;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   19-OCT-2011, sequence version 3.
DT   10-MAY-2017, entry version 157.
DE   RecName: Full=Triosephosphate isomerase;
DE            Short=TIM;
DE            EC=5.3.1.1;
DE   AltName: Full=Triose-phosphate isomerase;
GN   Name=TPI1; Synonyms=TPI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2579079;
RA   Maquat L.E., Chilcote R., Ryan P.M.;
RT   "Human triosephosphate isomerase cDNA and protein structure. Studies
RT   of triosephosphate isomerase deficiency in man.";
RL   J. Biol. Chem. 260:3748-3753(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=4022011; DOI=10.1128/MCB.5.7.1694;
RA   Brown J.R., Daar I.O., Krug J.R., Maquat L.E.;
RT   "Characterization of the functional gene and several processed
RT   pseudogenes in the human triosephosphate isomerase gene family.";
RL   Mol. Cell. Biol. 5:1694-1706(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8723724; DOI=10.1101/gr.6.4.314;
RA   Ansari-Lari M.A., Muzny D.M., Lu J., Lu F., Lilley C.E., Spanos S.,
RA   Malley T., Gibbs R.A.;
RT   "A gene-rich cluster between the CD4 and triosephosphate isomerase
RT   genes at human chromosome 12p13.";
RL   Genome Res. 6:314-326(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9074930; DOI=10.1101/gr.7.3.268;
RA   Ansari-Lari M.A., Shen Y., Muzny D.M., Lee W., Gibbs R.A.;
RT   "Large-scale sequencing in human chromosome 12p13: experimental and
RT   computational gene structure determination.";
RL   Genome Res. 7:268-280(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 27-286 (ISOFORM 1).
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-42.
RX   PubMed=2925688;
RA   Boyer T.G., Krug J.R., Maquat L.E.;
RT   "Transcriptional regulatory sequences of the housekeeping gene for
RT   human triosephosphate isomerase.";
RL   J. Biol. Chem. 264:5177-5187(1989).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 26-286 (ISOFORM 1).
RC   TISSUE=Brain, Kidney, Placenta, Prostate, Skeletal muscle, Skin, and
RC   Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 38-286 (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   PROTEIN SEQUENCE OF 39-286.
RX   PubMed=6434534;
RA   Lu H.S., Yuan P.M., Gracy R.W.;
RT   "Primary structure of human triosephosphate isomerase.";
RL   J. Biol. Chem. 259:11958-11968(1984).
RN   [12]
RP   PROTEIN SEQUENCE OF 39-57.
RC   TISSUE=Mammary carcinoma;
RX   PubMed=9150946; DOI=10.1002/elps.1150180342;
RA   Rasmussen R.K., Ji H., Eddes J.S., Moritz R.L., Reid G.E.,
RA   Simpson R.J., Dorow D.S.;
RT   "Two-dimensional electrophoretic analysis of human breast carcinoma
RT   proteins: mapping of proteins that bind to the SH3 domain of mixed
RT   lineage kinase MLK2.";
RL   Electrophoresis 18:588-598(1997).
RN   [13]
RP   PROTEIN SEQUENCE OF 39-57.
RC   TISSUE=Colon carcinoma;
RX   PubMed=9150948; DOI=10.1002/elps.1150180344;
RA   Ji H., Reid G.E., Moritz R.L., Eddes J.S., Burgess A.W., Simpson R.J.;
RT   "A two-dimensional gel database of human colon carcinoma proteins.";
RL   Electrophoresis 18:605-613(1997).
RN   [14]
RP   PROTEIN SEQUENCE OF 43-51; 56-90; 97-168; 180-193; 198-212 AND
RP   232-256, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pituitary;
RX   PubMed=16807684; DOI=10.1007/s11102-006-8916-x;
RA   Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.;
RT   "Phosphoproteomic analysis of the human pituitary.";
RL   Pituitary 9:109-120(2006).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17693683; DOI=10.1074/mcp.M700120-MCP200;
RA   Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,
RA   Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
RT   "Quantitative phosphoproteome profiling of Wnt3a-mediated signaling
RT   network: indicating the involvement of ribonucleoside-diphosphate
RT   reductase M2 subunit phosphorylation at residue serine 20 in canonical
RT   Wnt signal transduction.";
RL   Mol. Cell. Proteomics 6:1952-1967(2007).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58 AND SER-117, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-51; LYS-231 AND LYS-275, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58; SER-117 AND SER-249,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58; SER-249; THR-251 AND
RP   SER-260, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [30]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT LYS-231, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [31]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-179, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 39-286 IN COMPLEX WITH
RP   SUBSTRATE ANALOG, AND HOMODIMERIZATION.
RX   PubMed=8061610; DOI=10.1002/pro.5560030510;
RA   Mande S.C., Mainfroid V., Kalk K.H., Goraj K., Martial J.A.,
RA   Hol W.G.J.;
RT   "Crystal structure of recombinant human triosephosphate isomerase at
RT   2.8-A resolution. Triosephosphate isomerase-related human genetic
RT   disorders and comparison with the trypanosomal enzyme.";
RL   Protein Sci. 3:810-821(1994).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 39-286.
RX   PubMed=16511037; DOI=10.1107/S1744309105008341;
RA   Kinoshita T., Maruki R., Warizaya M., Nakajima H., Nishimura S.;
RT   "Structure of a high-resolution crystal form of human triosephosphate
RT   isomerase: improvement of crystals using the gel-tube method.";
RL   Acta Crystallogr. F 61:346-349(2005).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 39-289 OF MUTANT ASP-142,
RP   SUBUNIT, AND CHARACTERIZATION OF VARIANT ASP-142.
RX   PubMed=18562316; DOI=10.1074/jbc.M802145200;
RA   Rodriguez-Almazan C., Arreola R., Rodriguez-Larrea D.,
RA   Aguirre-Lopez B., de Gomez-Puyou M.T., Perez-Montfort R., Costas M.,
RA   Gomez-Puyou A., Torres-Larios A.;
RT   "Structural basis of human triosephosphate isomerase deficiency:
RT   mutation E104D is related to alterations of a conserved water network
RT   at the dimer interface.";
RL   J. Biol. Chem. 283:23254-23263(2008).
RN   [36]
RP   VARIANT TPID ASP-142.
RX   PubMed=2876430; DOI=10.1073/pnas.83.20.7903;
RA   Daar I.O., Artymiuk P.J., Phillips D.C., Maquat L.E.;
RT   "Human triose-phosphate isomerase deficiency: a single amino acid
RT   substitution results in a thermolabile enzyme.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:7903-7907(1986).
RN   [37]
RP   VARIANTS TPID ASP-142 AND MET-269.
RA   Neubauer B.A., Pekrun A., Eber S.W., Lakomek M., Schroeter W.;
RT   "Relation between genetic defect, altered protein structure, and
RT   enzyme function in triose-phosphate isomerase (TPI) deficiency.";
RL   Eur. J. Pediatr. Suppl. 151:232-232(1992).
RN   [38]
RP   VARIANT MANCHESTER ARG-160.
RX   PubMed=1339398; DOI=10.1007/BF02265287;
RA   Perry B.A., Mohrenweiser H.W.;
RT   "Human triosephosphate isomerase: substitution of Arg for Gly at
RT   position 122 in a thermolabile electromorph variant, TPI-Manchester.";
RL   Hum. Genet. 88:634-638(1992).
RN   [39]
RP   VARIANT TPID HUNGARY LEU-278.
RX   PubMed=8503454;
RA   Chang M.-L., Artymiuk P.J., Wu X., Hollan S., Lammi A., Maquat L.E.;
RT   "Human triosephosphate isomerase deficiency resulting from mutation of
RT   Phe-240.";
RL   Am. J. Hum. Genet. 52:1260-1269(1993).
RN   [40]
RP   VARIANTS TPID ALA-110; ASP-142 AND MET-192.
RX   PubMed=8571957;
RA   Watanabe M., Zingg B.C., Mohrenweiser H.W.;
RT   "Molecular analysis of a series of alleles in humans with reduced
RT   activity at the triosephosphate isomerase locus.";
RL   Am. J. Hum. Genet. 58:308-316(1996).
RN   [41]
RP   VARIANTS TPID TYR-79; ASP-142 AND VAL-208.
RX   PubMed=9338582;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:4<290::AID-HUMU4>3.3.CO;2-F;
RA   Arya R., Lalloz M.R.A., Bellingham A.J., Layton D.M.;
RT   "Evidence for founder effect of the Glu104Asp substitution and
RT   identification of new mutations in triosephosphate isomerase
RT   deficiency.";
RL   Hum. Mutat. 10:290-294(1997).
CC   -!- CATALYTIC ACTIVITY: D-glyceraldehyde 3-phosphate = glycerone
CC       phosphate.
CC   -!- PATHWAY: Carbohydrate biosynthesis; gluconeogenesis.
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-
CC       phosphate from glycerone phosphate: step 1/1.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:18562316,
CC       ECO:0000269|PubMed:8061610}.
CC   -!- INTERACTION:
CC       P12004:PCNA; NbExp=2; IntAct=EBI-717475, EBI-358311;
CC       P54274:TERF1; NbExp=2; IntAct=EBI-717475, EBI-710997;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P60174-3; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P60174-1; Sequence=VSP_041895;
CC       Name=4;
CC         IsoId=P60174-4; Sequence=VSP_045310;
CC         Note=Produced by alternative splicing.;
CC   -!- PTM: The initiator methionine for isoform 2 is removed.
CC   -!- DISEASE: Triosephosphate isomerase deficiency (TPID) [MIM:615512]:
CC       An autosomal recessive multisystem disorder characterized by
CC       congenital hemolytic anemia, progressive neuromuscular
CC       dysfunction, susceptibility to bacterial infection, and
CC       cardiomyopathy. {ECO:0000269|PubMed:2876430,
CC       ECO:0000269|PubMed:8503454, ECO:0000269|PubMed:8571957,
CC       ECO:0000269|PubMed:9338582, ECO:0000269|Ref.37}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the triosephosphate isomerase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB51316.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAB59511.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH07086.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH07812.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH09329.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH11611.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH15100.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH17917.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH70129.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH70129.1; Type=Miscellaneous discrepancy; Note=Sequence differs at the C-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAN86636.1; Type=Frameshift; Positions=23; Evidence={ECO:0000305};
CC       Sequence=BAG36090.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAA49379.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Triosephosphate isomerase
CC       entry;
CC       URL="https://en.wikipedia.org/wiki/Triosephosphate_isomerase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M10036; AAB59511.1; ALT_INIT; mRNA.
DR   EMBL; X69723; CAA49379.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AK298809; BAH12874.1; -; mRNA.
DR   EMBL; U47924; AAB51316.1; ALT_INIT; Genomic_DNA.
DR   EMBL; CH471116; EAW88722.1; -; Genomic_DNA.
DR   EMBL; CH471116; EAW88723.1; -; Genomic_DNA.
DR   EMBL; J04603; AAN86636.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; BC007086; AAH07086.1; ALT_INIT; mRNA.
DR   EMBL; BC007812; AAH07812.1; ALT_INIT; mRNA.
DR   EMBL; BC009329; AAH09329.1; ALT_INIT; mRNA.
DR   EMBL; BC011611; AAH11611.1; ALT_INIT; mRNA.
DR   EMBL; BC015100; AAH15100.1; ALT_INIT; mRNA.
DR   EMBL; BC017165; AAH17165.1; -; mRNA.
DR   EMBL; BC017917; AAH17917.1; ALT_INIT; mRNA.
DR   EMBL; BC070129; AAH70129.1; ALT_SEQ; mRNA.
DR   EMBL; AK313282; BAG36090.1; ALT_INIT; mRNA.
DR   EMBL; CR541702; CAG46503.1; -; mRNA.
DR   CCDS; CCDS53740.1; -. [P60174-3]
DR   CCDS; CCDS58206.1; -. [P60174-4]
DR   CCDS; CCDS8566.1; -. [P60174-1]
DR   PIR; S29743; ISHUT.
DR   RefSeq; NP_000356.1; NM_000365.5. [P60174-1]
DR   RefSeq; NP_001152759.1; NM_001159287.1. [P60174-3]
DR   RefSeq; NP_001244955.1; NM_001258026.1. [P60174-4]
DR   UniGene; Hs.524219; -.
DR   PDB; 1HTI; X-ray; 2.80 A; A/B=39-286.
DR   PDB; 1KLG; X-ray; 2.40 A; C=60-74.
DR   PDB; 1KLU; X-ray; 1.93 A; C=60-74.
DR   PDB; 1WYI; X-ray; 2.20 A; A/B=39-286.
DR   PDB; 2IAM; X-ray; 2.80 A; P=60-74.
DR   PDB; 2IAN; X-ray; 2.80 A; C/H/M/R=60-74.
DR   PDB; 2JK2; X-ray; 1.70 A; A/B=39-286.
DR   PDB; 2VOM; X-ray; 1.85 A; A/B/C/D=39-286.
DR   PDB; 4BR1; X-ray; 1.90 A; A/B=41-286.
DR   PDB; 4E41; X-ray; 2.60 A; C/H=60-74.
DR   PDB; 4POC; X-ray; 1.60 A; A/B=38-286.
DR   PDB; 4POD; X-ray; 1.99 A; A/B=38-286.
DR   PDB; 4UNK; X-ray; 2.00 A; A/B=39-286.
DR   PDB; 4UNL; X-ray; 1.50 A; A/B=39-286.
DR   PDB; 4ZVJ; X-ray; 1.70 A; A/B=38-286.
DR   PDBsum; 1HTI; -.
DR   PDBsum; 1KLG; -.
DR   PDBsum; 1KLU; -.
DR   PDBsum; 1WYI; -.
DR   PDBsum; 2IAM; -.
DR   PDBsum; 2IAN; -.
DR   PDBsum; 2JK2; -.
DR   PDBsum; 2VOM; -.
DR   PDBsum; 4BR1; -.
DR   PDBsum; 4E41; -.
DR   PDBsum; 4POC; -.
DR   PDBsum; 4POD; -.
DR   PDBsum; 4UNK; -.
DR   PDBsum; 4UNL; -.
DR   PDBsum; 4ZVJ; -.
DR   ProteinModelPortal; P60174; -.
DR   SMR; P60174; -.
DR   BioGrid; 113020; 87.
DR   IntAct; P60174; 17.
DR   MINT; MINT-1384176; -.
DR   STRING; 9606.ENSP00000229270; -.
DR   BindingDB; P60174; -.
DR   ChEMBL; CHEMBL4880; -.
DR   DrugBank; DB03379; 2-Carboxyethylphosphonic Acid.
DR   DrugBank; DB03900; 2-Methyl-2-Propanol.
DR   DrugBank; DB02726; 2-Phosphoglycolic Acid.
DR   DrugBank; DB03132; 3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid.
DR   DrugBank; DB07387; 3-(BUTYLSULPHONYL)-PROPANOIC ACID.
DR   DrugBank; DB04510; 3-Phosphoglyceric Acid.
DR   DrugBank; DB03135; [2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid.
DR   DrugBank; DB03314; Fluorotryptophane.
DR   DrugBank; DB01695; N-Hydroxy-4-Phosphono-Butanamide.
DR   DrugBank; DB03026; Phosphoglycolohydroxamic Acid.
DR   iPTMnet; P60174; -.
DR   PhosphoSitePlus; P60174; -.
DR   SwissPalm; P60174; -.
DR   BioMuta; TPI1; -.
DR   DMDM; 353526311; -.
DR   DOSAC-COBS-2DPAGE; P60174; -.
DR   REPRODUCTION-2DPAGE; IPI00797687; -.
DR   REPRODUCTION-2DPAGE; P60174; -.
DR   SWISS-2DPAGE; P60174; -.
DR   UCD-2DPAGE; P60174; -.
DR   EPD; P60174; -.
DR   MaxQB; P60174; -.
DR   PaxDb; P60174; -.
DR   PeptideAtlas; P60174; -.
DR   PRIDE; P60174; -.
DR   TopDownProteomics; P60174-1; -. [P60174-1]
DR   TopDownProteomics; P60174-3; -. [P60174-3]
DR   TopDownProteomics; P60174-4; -. [P60174-4]
DR   DNASU; 7167; -.
DR   Ensembl; ENST00000229270; ENSP00000229270; ENSG00000111669. [P60174-3]
DR   Ensembl; ENST00000396705; ENSP00000379933; ENSG00000111669. [P60174-1]
DR   Ensembl; ENST00000488464; ENSP00000475620; ENSG00000111669. [P60174-4]
DR   Ensembl; ENST00000535434; ENSP00000443599; ENSG00000111669. [P60174-4]
DR   Ensembl; ENST00000613953; ENSP00000484435; ENSG00000111669. [P60174-3]
DR   GeneID; 7167; -.
DR   KEGG; hsa:7167; -.
DR   UCSC; uc001qrk.5; human. [P60174-3]
DR   CTD; 7167; -.
DR   DisGeNET; 7167; -.
DR   GeneCards; TPI1; -.
DR   HGNC; HGNC:12009; TPI1.
DR   HPA; HPA050924; -.
DR   HPA; HPA053568; -.
DR   MalaCards; TPI1; -.
DR   MIM; 190450; gene.
DR   MIM; 615512; phenotype.
DR   neXtProt; NX_P60174; -.
DR   OpenTargets; ENSG00000111669; -.
DR   Orphanet; 868; Triose phosphate-isomerase deficiency.
DR   PharmGKB; PA36689; -.
DR   eggNOG; KOG1643; Eukaryota.
DR   eggNOG; COG0149; LUCA.
DR   GeneTree; ENSGT00390000013354; -.
DR   HOGENOM; HOG000226413; -.
DR   HOVERGEN; HBG002599; -.
DR   InParanoid; P60174; -.
DR   KO; K01803; -.
DR   OMA; FERRKFF; -.
DR   OrthoDB; EOG091G0LEZ; -.
DR   PhylomeDB; P60174; -.
DR   TreeFam; TF300829; -.
DR   BioCyc; MetaCyc:HS03441-MONOMER; -.
DR   BRENDA; 5.3.1.1; 2681.
DR   Reactome; R-HSA-70171; Glycolysis.
DR   Reactome; R-HSA-70263; Gluconeogenesis.
DR   SABIO-RK; P60174; -.
DR   UniPathway; UPA00109; UER00189.
DR   UniPathway; UPA00138; -.
DR   ChiTaRS; TPI1; human.
DR   EvolutionaryTrace; P60174; -.
DR   GeneWiki; TPI1; -.
DR   GenomeRNAi; 7167; -.
DR   PRO; PR:P60174; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000111669; -.
DR   CleanEx; HS_TPI1; -.
DR   ExpressionAtlas; P60174; baseline and differential.
DR   Genevisible; P60174; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004807; F:triose-phosphate isomerase activity; EXP:Reactome.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0061621; P:canonical glycolysis; TAS:Reactome.
DR   GO; GO:0006094; P:gluconeogenesis; IBA:GO_Central.
DR   GO; GO:0046166; P:glyceraldehyde-3-phosphate biosynthetic process; IBA:GO_Central.
DR   GO; GO:0019563; P:glycerol catabolic process; IBA:GO_Central.
DR   GO; GO:0006096; P:glycolytic process; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IEA:Ensembl.
DR   GO; GO:0006098; P:pentose-phosphate shunt; IEA:UniProtKB-KW.
DR   CDD; cd00311; TIM; 1.
DR   Gene3D; 3.20.20.70; -; 1.
DR   HAMAP; MF_00147_B; TIM_B; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR022896; TrioseP_Isoase_bac/euk.
DR   InterPro; IPR000652; Triosephosphate_isomerase.
DR   InterPro; IPR020861; Triosephosphate_isomerase_AS.
DR   PANTHER; PTHR21139; PTHR21139; 1.
DR   Pfam; PF00121; TIM; 1.
DR   SUPFAM; SSF51351; SSF51351; 1.
DR   TIGRFAMs; TIGR00419; tim; 1.
DR   PROSITE; PS00171; TIM_1; 1.
DR   PROSITE; PS51440; TIM_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative promoter usage;
KW   Alternative splicing; Complete proteome; Direct protein sequencing;
KW   Disease mutation; Gluconeogenesis; Glycolysis;
KW   Hereditary hemolytic anemia; Isomerase; Isopeptide bond; Methylation;
KW   Nitration; Pentose shunt; Phosphoprotein; Polymorphism;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN         1    286       Triosephosphate isomerase.
FT                                /FTId=PRO_0000090113.
FT   ACT_SITE    133    133       Electrophile.
FT   ACT_SITE    203    203       Proton acceptor.
FT   BINDING      49     49       Substrate.
FT   BINDING      51     51       Substrate.
FT   MOD_RES      51     51       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      58     58       Phosphoserine.
FT                                {ECO:0000244|PubMed:16807684,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:17693683,
FT                                ECO:0000244|PubMed:17924679,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19367720,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     105    105       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:P17751}.
FT   MOD_RES     117    117       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     143    143       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P48500}.
FT   MOD_RES     186    186       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P17751}.
FT   MOD_RES     193    193       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P17751}.
FT   MOD_RES     193    193       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P17751}.
FT   MOD_RES     196    196       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P17751}.
FT   MOD_RES     210    210       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P17751}.
FT   MOD_RES     231    231       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     231    231       N6-methyllysine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     231    231       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P17751}.
FT   MOD_RES     235    235       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P48500}.
FT   MOD_RES     246    246       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:P17751}.
FT   MOD_RES     249    249       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     251    251       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     260    260       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     275    275       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   CROSSLNK    179    179       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1).
FT                                {ECO:0000244|PubMed:25114211}.
FT   VAR_SEQ       1    119       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045310.
FT   VAR_SEQ       1     37       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_041895.
FT   VARIANT      79     79       C -> Y (in TPID; dbSNP:rs121964848).
FT                                {ECO:0000269|PubMed:9338582}.
FT                                /FTId=VAR_007534.
FT   VARIANT     110    110       G -> A (in TPID).
FT                                {ECO:0000269|PubMed:8571957}.
FT                                /FTId=VAR_007535.
FT   VARIANT     142    142       E -> D (in TPID; the enzyme becomes
FT                                thermolabile; dbSNP:rs121964845).
FT                                {ECO:0000269|PubMed:18562316,
FT                                ECO:0000269|PubMed:2876430,
FT                                ECO:0000269|PubMed:8571957,
FT                                ECO:0000269|PubMed:9338582,
FT                                ECO:0000269|Ref.37}.
FT                                /FTId=VAR_007536.
FT   VARIANT     160    160       G -> R (in Manchester; thermolabile;
FT                                dbSNP:rs121964846).
FT                                {ECO:0000269|PubMed:1339398}.
FT                                /FTId=VAR_007537.
FT   VARIANT     192    192       V -> M (in TPID; dbSNP:rs188138723).
FT                                {ECO:0000269|PubMed:8571957}.
FT                                /FTId=VAR_007538.
FT   VARIANT     208    208       I -> V (in TPID; dbSNP:rs121964849).
FT                                {ECO:0000269|PubMed:9338582}.
FT                                /FTId=VAR_007539.
FT   VARIANT     269    269       V -> M (in TPID). {ECO:0000269|Ref.37}.
FT                                /FTId=VAR_007540.
FT   VARIANT     278    278       F -> L (in TPID; Hungary; thermolabile;
FT                                dbSNP:rs121964847).
FT                                {ECO:0000269|PubMed:8503454}.
FT                                /FTId=VAR_007541.
FT   CONFLICT     23     26       RLRA -> TAR (in Ref. 1; AAB59511).
FT                                {ECO:0000305}.
FT   CONFLICT     36     36       Missing (in Ref. 1; AAB59511 and 6;
FT                                AAN86636). {ECO:0000305}.
FT   CONFLICT     57     58       QS -> KN (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     64     64       G -> S (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     67     68       NA -> QG (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     80     81       AP -> IG (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     95     95       P -> Q (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    192    192       V -> A (in Ref. 9; AAH17917).
FT                                {ECO:0000305}.
FT   CONFLICT    204    204       P -> N (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    281    281       I -> L (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND       44     49       {ECO:0000244|PDB:4UNL}.
FT   HELIX        56     68       {ECO:0000244|PDB:4UNL}.
FT   STRAND       75     80       {ECO:0000244|PDB:4UNL}.
FT   HELIX        83     85       {ECO:0000244|PDB:4UNL}.
FT   HELIX        86     92       {ECO:0000244|PDB:4UNL}.
FT   STRAND       97    102       {ECO:0000244|PDB:4UNL}.
FT   STRAND      106    111       {ECO:0000244|PDB:4UNL}.
FT   HELIX       118    123       {ECO:0000244|PDB:4UNL}.
FT   STRAND      128    132       {ECO:0000244|PDB:4UNL}.
FT   HELIX       134    138       {ECO:0000244|PDB:4UNL}.
FT   HELIX       144    156       {ECO:0000244|PDB:4UNL}.
FT   STRAND      160    165       {ECO:0000244|PDB:4UNL}.
FT   HELIX       169    173       {ECO:0000244|PDB:4UNL}.
FT   HELIX       177    190       {ECO:0000244|PDB:4UNL}.
FT   HELIX       195    197       {ECO:0000244|PDB:4UNL}.
FT   STRAND      198    202       {ECO:0000244|PDB:4UNL}.
FT   HELIX       205    207       {ECO:0000244|PDB:4UNL}.
FT   TURN        208    210       {ECO:0000244|PDB:4UNL}.
FT   HELIX       216    233       {ECO:0000244|PDB:4UNL}.
FT   HELIX       236    241       {ECO:0000244|PDB:4UNL}.
FT   STRAND      244    246       {ECO:0000244|PDB:4UNL}.
FT   TURN        252    254       {ECO:0000244|PDB:4UNL}.
FT   HELIX       255    260       {ECO:0000244|PDB:4UNL}.
FT   STRAND      266    269       {ECO:0000244|PDB:4UNL}.
FT   HELIX       271    274       {ECO:0000244|PDB:4UNL}.
FT   HELIX       277    282       {ECO:0000244|PDB:4UNL}.
FT   TURN        283    285       {ECO:0000244|PDB:4UNL}.
SQ   SEQUENCE   286 AA;  30791 MW;  E6C2157706AE97F8 CRC64;
     MAEDGEEAEF HFAALYISGQ WPRLRADTDL QRLGSSAMAP SRKFFVGGNW KMNGRKQSLG
     ELIGTLNAAK VPADTEVVCA PPTAYIDFAR QKLDPKIAVA AQNCYKVTNG AFTGEISPGM
     IKDCGATWVV LGHSERRHVF GESDELIGQK VAHALAEGLG VIACIGEKLD EREAGITEKV
     VFEQTKVIAD NVKDWSKVVL AYEPVWAIGT GKTATPQQAQ EVHEKLRGWL KSNVSDAVAQ
     STRIIYGGSV TGATCKELAS QPDVDGFLVG GASLKPEFVD IINAKQ
//
